{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T21:27:22Z","timestamp":1787174842331,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1F31AI181431-01A1"],"award-info":[{"award-number":["1F31AI181431-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI068617"],"award-info":[{"award-number":["UM1 AI068617"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.lana.2026.101502","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:18:47Z","timestamp":1779808727000},"page":"101502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating the potential health and economic impacts of chlamydia vaccination strategies in the United States: a mathematical modeling and cost-effectiveness simulation study"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7169-3762","authenticated-orcid":false,"given":"Gregory K.","family":"Zane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dobromir","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol E.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Khosropour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3399-2208","authenticated-orcid":false,"given":"Ann","family":"Duerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lana.2026.101502_bib2","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1097\/OLQ.0000000000000858","article-title":"The proportion of young women tested for chlamydia who had urogenital symptoms in physician offices","volume":"45","author":"Patel","year":"2018","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.lana.2026.101502_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1363\/4122509","article-title":"Relationships between perceived STD-Related Stigma, STD-Related Shame and STD Screening Among a Household Sample of Adolescents","volume":"41","author":"Cunningham","year":"2009","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.lana.2026.101502_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/OLQ.0b013e318285c6d2","article-title":"The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008","volume":"40","author":"Owusu-Edusei","year":"2013","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.lana.2026.101502_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/OLQ.0000000000001380","article-title":"The estimated direct lifetime medical costs of sexually transmitted infections acquired in the United States in 2018","volume":"48","author":"Chesson","year":"2021","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.lana.2026.101502_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/OLQ.0000000000001973","article-title":"Estimates of the lifetime productivity costs of chlamydia, Gonorrhea, and Syphilis in the United States","volume":"51","author":"Chesson","year":"2024","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.lana.2026.101502_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2021.14081","article-title":"Screening for chlamydia and gonorrhea: US preventive services task force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.lana.2026.101502_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/OLQ.0000000000001809","article-title":"National chlamydia screening rate in young sexually active women using HEDIS measures in the United States, 2011 to 2020","volume":"50","author":"He","year":"2023","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.lana.2026.101502_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","article-title":"CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024","volume":"73","author":"Bachmann","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.lana.2026.101502_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftae017","article-title":"Advances in vaccine development for Chlamydia trachomatis","volume":"82","author":"Poston","year":"2024","journal-title":"Pathog Dis"},{"key":"10.1016\/j.lana.2026.101502_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2023-000345","article-title":"Impact of a potential Chlamydia vaccine in the USA: mathematical modelling analyses","volume":"2","author":"Makhoul","year":"2024","journal-title":"BMJ Public Health"},{"key":"10.1016\/j.lana.2026.101502_bib12","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3201\/eid2106.141270","article-title":"Cost-effectiveness of Chlamydia vaccination programs for young women","volume":"21","author":"Owusu-Edusei","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.lana.2026.101502_bib13","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1086\/598983","article-title":"Modelling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection","volume":"199","author":"Gray","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lana.2026.101502_bib14","first-page":"296","article-title":"Cost\u2013Benefit analysis of a chlamydia trachomatis vaccine program in adolescent girls in the United States","volume":"7","author":"Ditkowsky","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.lana.2026.101502_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s44263-025-00181-7","article-title":"Vaccination as a strategy for Chlamydia trachomatis control: a global mathematical modeling analysis","volume":"3","author":"Makhoul","year":"2025","journal-title":"BMC Glob Public Health"},{"key":"10.1016\/j.lana.2026.101502_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10441-014-9234-8","article-title":"Mathematical analysis of a chlamydia epidemic model with pulse vaccination strategy","volume":"63","author":"Samanta","year":"2015","journal-title":"Acta Biotheor"},{"key":"10.1016\/j.lana.2026.101502_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/OLQ.0000000000000598","article-title":"The use of mathematical models of chlamydia transmission to address public health policy questions: a systematic review","volume":"44","author":"R\u00f6nn","year":"2017","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.lana.2026.101502_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/sextrans-2018-053543","article-title":"Original article: does infection with Chlamydia trachomatis induce long-lasting partial immunity? Insights from mathematical modelling","volume":"95","author":"Omori","year":"2019","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.lana.2026.101502_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/OLQ.0000000000001772","article-title":"Assortative sexual mixing by age, region of birth, and time of arrival in male-female partnerships in Melbourne, Australia","volume":"50","author":"Greaves","year":"2023","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.lana.2026.101502_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/OLQ.0000000000001382","article-title":"Estimates of the prevalence and incidence of chlamydia and gonorrhea among US men and women, 2018","volume":"48","author":"Kreisel","year":"2021","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.lana.2026.101502_bib23","series-title":"Current CDC vaccine price list","year":"2025"},{"key":"10.1016\/j.lana.2026.101502_bib25","series-title":"Measurement and valuation of health for economic evaluation","first-page":"586","author":"Brazier","year":"2017"},{"key":"10.1016\/j.lana.2026.101502_bib26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/infdis\/jiad047","article-title":"The estimated lifetime quality-adjusted life-years lost due to Chlamydia, gonorrhea, and trichomoniasis in the United States in 2018","volume":"227","author":"Li","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lana.2026.101502_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737167.8.2.165","article-title":"Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold","volume":"8","author":"Grosse","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.lana.2026.101502_bib28","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-060410","article-title":"Trends in reasons for human Papillomavirus vaccine hesitancy: 2010-2020","volume":"151","author":"Adjei Boakye","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.lana.2026.101502_bib29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/sextrans-2021-054992","article-title":"Where to go to in chlamydia control? From infection control towards infectious disease control","volume":"97","author":"Van Bergen","year":"2021","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.lana.2026.101502_bib30","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/vaccines11071259","article-title":"A systematic review of behaviour change techniques within interventions to increase vaccine uptake among ethnic minority populations","volume":"11","author":"Ekezie","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lana.2026.101502_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40738-021-00098-3","article-title":"The prevalence of depression symptoms among infertile women: a systematic review and meta-analysis","volume":"7","author":"Kiani","year":"2021","journal-title":"Fertil Res Pract"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26001328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26001328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:50:45Z","timestamp":1787172645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X26001328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"alternative-id":["S2667193X26001328"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2026.101502","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the potential health and economic impacts of chlamydia vaccination strategies in the United States: a mathematical modeling and cost-effectiveness simulation study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2026.101502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101502"}}